In-vitro Diagnostics Enzymes Market, By Enzyme (Proteases, Polymerase & Transcriptase, and Ribonuclease), By Disease, By Technology, By End Use, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033
|
Report ID
AV5303
|
Published Date
June 2026
|
Pages
353
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
In-vitro Diagnostics Enzymes Market size was valued at US$ 1,876.93 Million in 2025, expanding at a CAGR of 9.34% from 2026 to 2033.
In vitro diagnostics (IVD) enzymes are specialized biological catalysts that facilitate precise biochemical reactions in diagnostic testing, enabling accurate detection and analysis of diseases. These enzymes play a critical role in a wide range of biochemical and molecular diagnostic applications, particularly in biotechnology and clinical disease detection. The IVD enzymes market is experiencing steady growth, driven by the increasing adoption of enzyme-based diagnostic assays and advancements in healthcare diagnostics.
For instance, research published in IJERT highlights that machine learning-based systems, particularly Convolutional Neural Networks (CNNs), are being increasingly utilized to enhance disease diagnosis accuracy. The study notes that CNN models deliver improved disease detection from medical imaging, offering higher precision and more consistent results compared to conventional diagnostic approaches. These technological advancements are supporting more accurate and efficient diagnostic processes, thereby increasing demand for advanced enzyme-based diagnostic technologies in the healthcare sector.
In-vitro Diagnostics Enzymes Market- Market Dynamics
Growing Biotechnology and Molecular Diagnostic Innovations Fueling Market Demand
The field of molecular diagnostics is evolving rapidly through the adoption of high-sensitivity techniques that enable precise detection of DNA and RNA variations, significantly improving disease identification and genetic analysis. The increasing use of PCR-based systems, mass spectrometry, and multiplex platforms is enhancing the detection of infectious diseases, cancer biomarkers, and genetic disorders with greater speed and accuracy. In addition, multi-parametric diagnostic approaches that integrate molecular and imaging technologies are improving diagnostic specificity and enabling more comprehensive disease profiling.
Advancements in biotechnology and molecular diagnostics are playing a key role in driving the in vitro diagnostics enzymes market by enabling higher accuracy, faster testing, and improved sensitivity in diagnostic assays for disease detection and monitoring. According to research published on NIH.gov (2025), rapid progress in biotechnology and molecular diagnostics is significantly transforming disease detection and clinical decision-making. The study highlights that modern diagnostic platforms, including PCR-based assays, next-generation sequencing (NGS), CRISPR-based detection systems, and microfluidic lab-on-chip technologies, have reduced diagnostic turnaround times from several days to just a few hours. These innovations have also improved diagnostic sensitivity and specificity to over 90–95% in applications such as pathogen detection and cancer biomarker identification, enabling earlier and more accurate diagnosis.
In-vitro Diagnostics Enzymes Market- Segmentation Analysis:
The Global In-vitro Diagnostics Enzymes Market is segmented on the basis of Enzyme, Disease, Technology, End Use, and Region.
Based on enzyme type, proteases hold a significant position in the in vitro diagnostics enzymes market due to their extensive use in sample preparation, protein analysis, and various diagnostic assay applications. In May 2025, Roche launched the Elecsys® PRO-C3 test, a diagnostic assay designed to enhance liver fibrosis assessment through advanced protein analysis and more efficient diagnostic workflows. This development further reinforces the importance of proteases in improving the accuracy and efficiency of in vitro diagnostic applications.
In terms of disease application, infectious diseases represent a leading segment in the in vitro diagnostics enzymes market, driven by the increasing demand for rapid, accurate, and reliable diagnostic testing. According to research published by the NCBI Bookshelf, the rising burden of infectious diseases, along with the limitations of conventional diagnostic methods, is significantly increasing the need for improved diagnostic solutions. The study highlights that fewer than 30% of patients presenting with common urinary tract infection (UTI) symptoms are confirmed to have an actual infection, emphasizing the need for more precise diagnostic tools. Consequently, advancements in diagnostic technologies are improving accuracy and strengthening clinical decision-making outcomes.
In-vitro Diagnostics Enzymes Market- Geographical Insights
North America holds a leading position in the in vitro diagnostics enzymes market, supported by a highly developed healthcare infrastructure and widespread adoption of advanced diagnostic technologies. According to findings referenced in US government-related studies, the United States is undergoing a rapid shift toward molecular diagnostics, imaging technologies, and AI-assisted systems that enhance diagnostic speed, accuracy, and clinical decision-making. The analysis highlights that advanced diagnostic modalities such as molecular testing, point-of-care platforms, and digital or AI-enabled tools are increasingly being integrated into hospital and specialty care workflows, reflecting a broader modernization of the healthcare diagnostic ecosystem. This continued integration is improving diagnostic efficiency and supporting sustained market growth in the region.
In contrast, Asia Pacific is witnessing strong market expansion driven by the rising prevalence of chronic diseases, increasing demand for early and accurate diagnosis, and growing healthcare expenditure. According to OECD data, Japan maintains one of the most advanced healthcare systems within the OECD, with healthcare spending accounting for approximately 9.3% of GDP—higher than pre-pandemic levels of around 8.8%. This increase reflects a structural rise in healthcare investment driven by an aging population and growing medical needs. Consequently, rising healthcare expenditure and ongoing diagnostic modernization across the Asia Pacific are contributing significantly to market growth.
U.S In-vitro Diagnostics Enzymes Market - Country Insights
The United States plays a pivotal role in the in vitro diagnostics enzymes market, supported by advanced healthcare infrastructure, strong research capabilities, and widespread adoption of cutting-edge diagnostic technologies. In June 2025, Dyadic International continued advancing its enzyme production technology platforms for healthcare and diagnostic applications, focusing on improving biomanufacturing efficiency and supporting the development of high-performance enzymes used in in vitro diagnostic processes through ongoing research and development initiatives. These advancements are strengthening innovation and improving efficiency in enzyme-based diagnostic solutions across the country.
In-vitro Diagnostics Enzymes Market- Competitive Landscape:
The market is highly competitive, with companies focusing on innovation, product differentiation, and strategic collaborations to strengthen their global positions. Leading players such as Merck KGaA, Codexis, BBI Solutions, and Roche are enhancing enzyme performance by improving specificity, stability, and shelf life to meet evolving diagnostic requirements. Similarly, Amano Enzyme and Advanced Enzymes Technologies are investing heavily in R&D to develop high-performance enzymes for molecular diagnostics, immunoassays, and clinical chemistry applications, while also focusing on regulatory compliance and quality standards to support global expansion. In January 2026, Roche strengthened its in vitro diagnostics segment through continued investment in enzyme-based molecular diagnostic technologies, with a focus on next-generation PCR and immunoassay platforms aimed at enabling faster and more accurate disease detection.
Recent Developments
- In May 2025, Codexis advanced its enzyme engineering platform by expanding strategic collaborations focused on developing high-performance enzymes for molecular diagnostics applications, enhancing sensitivity and efficiency in in vitro diagnostic workflows.
- In March 2025, Merck KGaA expanded its diagnostics and life science portfolio by strengthening enzyme-based assay development capabilities through increased investment in advanced biocatalysis and molecular diagnostics research, aimed at improving precision and speed in in vitro diagnostic testing.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL IN-VITRO DIAGNOSTICS ENZYMES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Merck KGaA
- Codexis Inc.
- F. Hoffmann-La Roche Ltd.
- Amano Enzyme Inc.
- Advanced Enzymes Technologies Ltd.
- Biocatalysts Ltd.
- Amicogen Inc.
- Dyadic International Inc.
- BBI Solutions
- Affymetrix (Thermo Fisher Scientific)
- American Laboratories Inc.
- Others
GLOBAL IN-VITRO DIAGNOSTICS ENZYMES MARKET, BY ENZYME- MARKET ANALYSIS, 2020 - 2033
- Proteases
- Polymerase & Transcriptase
- Ribonuclease
- Others
GLOBAL IN-VITRO DIAGNOSTICS ENZYMES MARKET, BY DISEASE- MARKET ANALYSIS, 2020 - 2033
- Diabetes
- Oncology
- Cardiology
- Infectious disease
- HIV
- Hepatitis
- COVID-19 testing
- Others
- Nephrology
- Autoimmune diseases
- Others
GLOBAL IN-VITRO DIAGNOSTICS ENZYMES MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2020 - 2033
- Clinical Chemistry
- Molecular Diagnostics
- NGS Assays
- PCR Assays
- Others
- Histology Assays
- Others
GLOBAL IN-VITRO DIAGNOSTICS ENZYMES MARKET, BY END USE- MARKET ANALYSIS, 2020 - 2033
- Contract Research Organizations (CROs)
- Academic Labs
- Hospital & Diagnostic Labs
- Pharma & Biotech
- Others
GLOBAL IN-VITRO DIAGNOSTICS ENZYMES MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. In-vitro Diagnostics Enzymes Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. In-vitro Diagnostics Enzymes Market Snippet by Enzyme
2.1.2. In-vitro Diagnostics Enzymes Market Snippet by Disease
2.1.3. In-vitro Diagnostics Enzymes Market Snippet by Technology
2.1.4. In-vitro Diagnostics Enzymes Market Snippet by End Use
2.1.5. In-vitro Diagnostics Enzymes Market Snippet by Country
2.1.6. In-vitro Diagnostics Enzymes Market Snippet by Region
2.2. Competitive Insights
3. In-vitro Diagnostics Enzymes Key Market Trends
3.1. In-vitro Diagnostics Enzymes Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. In-vitro Diagnostics Enzymes Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. In-vitro Diagnostics Enzymes Market Opportunities
3.4. In-vitro Diagnostics Enzymes Market Future Trends
4. In-vitro Diagnostics Enzymes Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. In-vitro Diagnostics Enzymes Market : Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. In-vitro Diagnostics Enzymes Market Landscape
6.1. In-vitro Diagnostics Enzymes Market Share Analysis, 2025
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. In-vitro Diagnostics Enzymes Market – By Enzyme
7.1. Overview
7.1.1. Segment Share Analysis, By Enzyme, 2025 & 2033 (%)
7.1.2. Proteases
7.1.3. Polymerase & Transcriptase
7.1.4. Ribonuclease
7.1.5. Others
8. In-vitro Diagnostics Enzymes Market – By Disease
8.1. Overview
8.1.1. Segment Share Analysis, By Disease, 2025 & 2033 (%)
8.1.2. Diabetes
8.1.3. Oncology
8.1.4. Cardiology
8.1.5. Infectious disease
8.1.5.1. HIV
8.1.5.2. Hepatitis
8.1.5.3. COVID-19 testing
8.1.5.4. Others
8.1.6. Nephrology
8.1.7. Autoimmune diseases
8.1.8. Others
9. In-vitro Diagnostics Enzymes Market – By Technology
9.1. Overview
9.1.1. Segment Share Analysis, By Technology, 2025 & 2033 (%)
9.1.2. Clinical Chemistry
9.1.3. Molecular Diagnostics
9.1.3.1. NGS Assays
9.1.3.2. PCR Assays
9.1.3.3. Others
9.1.4. Histology Assays
9.1.5. Others
10. In-vitro Diagnostics Enzymes Market – By End Use
10.1. Overview
10.1.1. Segment Share Analysis, By Disease, 2025 & 2033 (%)
10.1.2. Contract Research Organizations (CROs)
10.1.3. Academic Labs
10.1.4. Hospital & Diagnostic Labs
10.1.5. Pharma & Biotech
10.1.6. Others
11. In-vitro Diagnostics Enzymes Market – By Geography
11.1. Introduction
11.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
11.2. North America
11.2.1. Overview
11.2.2. In-vitro Diagnostics Enzymes Key Manufacturers in North America
11.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.2.4. North America Market Size and Forecast, By Enzyme, 2020 - 2033 (US$ Million)
11.2.5. North America Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
11.2.6. North America Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.2.7. North America Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.2.8. U.S.
11.2.8.1. Overview
11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.2.8.3. U.S. Market Size and Forecast, By Enzyme, 2020 - 2033 (US$ Million)
11.2.8.4. U.S. Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
11.2.8.5. U.S. Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.2.8.6. U.S. Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.2.9. Canada
11.2.9.1. Overview
11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.2.9.3. Canada Market Size and Forecast, By Enzyme, 2020 - 2033 (US$ Million)
11.2.9.4. Canada Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
11.2.9.5. Canada Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.2.9.6. Canada Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.3. Europe
11.3.1. Overview
11.3.2. In-vitro Diagnostics Enzymes Key Manufacturers in Europe
11.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.3.4. Europe Market Size and Forecast, By Enzyme, 2020 - 2033 (US$ Million)
11.3.5. Europe Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
11.3.6. Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.7. Europe Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.3.8. Germany
11.3.8.1. Overview
11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.8.3. Germany Market Size and Forecast, By Enzyme, 2020 - 2033 (US$ Million)
11.3.8.4. Germany Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
11.3.8.5. Germany Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.8.6. Germany Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.3.9. UK
11.3.9.1. Overview
11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.9.3. UK Market Size and Forecast, By Enzyme, 2020 - 2033 (US$ Million)
11.3.9.4. UK Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
11.3.9.5. UK Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.9.6. UK Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.3.10. France
11.3.10.1. Overview
11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.10.3. France Market Size and Forecast, By Enzyme, 2020 - 2033 (US$ Million)
11.3.10.4. France Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
11.3.10.5. France Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.10.6. France Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.3.11. Italy
11.3.11.1. Overview
11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.11.3. Italy Market Size and Forecast, By Enzyme, 2020 - 2033 (US$ Million)
11.3.11.4. Italy Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
11.3.11.5. Italy Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.11.6. Italy Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.3.12. Spain
11.3.12.1. Overview
11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.12.3. Spain Market Size and Forecast, By Enzyme, 2020 - 2033 (US$ Million)
11.3.12.4. Spain Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
11.3.12.5. Spain Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.12.6. Spain Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.3.13. The Netherlands
11.3.13.1. Overview
11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.13.3. The Netherlands Market Size and Forecast, By Enzyme, 2020 - 2033 (US$ Million)
11.3.13.4. The Netherlands Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
11.3.13.5. The Netherlands Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.13.6. The Netherlands Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.3.14. Sweden
11.3.14.1. Overview
11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.14.3. Sweden Market Size and Forecast, By Enzyme, 2020 - 2033 (US$ Million)
11.3.14.4. Sweden Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
11.3.14.5. Sweden Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.14.6. Sweden Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.3.15. Russia
11.3.15.1. Overview
11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.15.3. Russia Market Size and Forecast, By Enzyme, 2020 - 2033 (US$ Million)
11.3.15.4. Russia Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
11.3.15.5. Russia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.15.6. Russia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.3.16. Poland
11.3.16.1. Overview
11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.16.3. Poland Market Size and Forecast, By Enzyme, 2020 - 2033 (US$ Million)
11.3.16.4. Poland Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
11.3.16.5. Poland Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.16.6. Poland Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.3.17. Denmark
11.3.17.1. Overview
11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.17.3. Poland Market Size and Forecast, By Enzyme, 2020 - 2033 (US$ Million)
11.3.17.4. Denmark Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
11.3.17.5. Denmark Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.17.6. Denmark Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.3.18. Rest of Europe
11.3.18.1. Overview
11.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.18.3. Rest of the Europe Market Size and Forecast, By Enzyme, 2020 - 2033 (US$ Million)
11.3.18.4. Rest of the Europe Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
11.3.18.5. Rest of the Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.18.6. Rest of the Europe Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.4. Asia Pacific (APAC)
11.4.1. Overview
11.4.2. In-vitro Diagnostics Enzymes Key Manufacturers in Asia Pacific
11.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.4.4. APAC Market Size and Forecast, By Enzyme, 2020 - 2033 (US$ Million)
11.4.5. APAC Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
11.4.6. APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.7. APAC Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.4.8. China
11.4.8.1. Overview
11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.8.3. China Market Size and Forecast, By Enzyme, 2020 - 2033 (US$ Million)
11.4.8.4. China Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
11.4.8.5. China Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.8.6. China Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.4.9. India
11.4.9.1. Overview
11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.9.3. India Market Size and Forecast, By Enzyme, 2020 - 2033 (US$ Million)
11.4.9.4. India Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
11.4.9.5. India Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.9.6. India Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.4.10. Japan
11.4.10.1. Overview
11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.10.3. Japan Market Size and Forecast, By Enzyme, 2020 - 2033 (US$ Million)
11.4.10.4. Japan Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
11.4.10.5. Japan Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.10.6. Japan Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.4.11. South Korea
11.4.11.1. Overview
11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.11.3. South Korea Market Size and Forecast, By Enzyme, 2020 - 2033 (US$ Million)
11.4.11.4. South Korea Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
11.4.11.5. South Korea Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.11.6. South Korea Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.4.12. Australia
11.4.12.1. Overview
11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.12.3. Australia Market Size and Forecast, By Enzyme, 2020 - 2033 (US$ Million)
11.4.12.4. Australia Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
11.4.12.5. Australia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.12.6. Australia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.4.13. Indonesia
11.4.13.1. Overview
11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.13.3. Indonesia Market Size and Forecast, By Enzyme, 2020 - 2033 (US$ Million)
11.4.13.4. Indonesia Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
11.4.13.5. Indonesia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.13.6. Indonesia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.4.14. Thailand
11.4.14.1. Overview
11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.14.3. Thailand Market Size and Forecast, By Enzyme, 2020 - 2033 (US$ Million)
11.4.14.4. Thailand Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
11.4.14.5. Thailand Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.14.6. Thailand Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.4.15. Philippines
11.4.15.1. Overview
11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.15.3. Philippines Market Size and Forecast, By Enzyme, 2020 - 2033 (US$ Million)
11.4.15.4. Philippines Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
11.4.15.5. Philippines Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.15.6. Philippines Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.4.16. Taiwan
11.4.16.1. Overview
11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.16.3. Taiwan Market Size and Forecast, By Enzyme, 2020 - 2033 (US$ Million)
11.4.16.4. Taiwan Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
11.4.16.5. Taiwan Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.16.6. Taiwan Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.4.17. Vietnam
11.4.17.1. Overview
11.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.17.3. Vietnam Market Size and Forecast, By Enzyme, 2020 - 2033 (US$ Million)
11.4.17.4. Vietnam Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
11.4.17.5. Vietnam Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.17.6. Vietnam Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.4.18. Rest of APAC
11.4.18.1. Overview
11.4.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.18.3. Rest of APAC Market Size and Forecast, By Enzyme, 2020 - 2033 (US$ Million)
11.4.18.4. Rest of APAC Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
11.4.18.5. Rest of APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.18.6. Rest of APAC Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.5. Latin America (LATAM)
11.5.1. Overview
11.5.2. In-vitro Diagnostics Enzymes Key Manufacturers in Latin America
11.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.5.4. LATAM Market Size and Forecast, By Enzyme, 2020 - 2033 (US$ Million)
11.5.5. LATAM Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
11.5.6. LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.5.7. LATAM Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.5.8. Brazil
11.5.8.1. Overview
11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.8.3. Brazil Market Size and Forecast, By Enzyme, 2020 - 2033 (US$ Million)
11.5.8.4. Brazil Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
11.5.8.5. Brazil Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.5.8.6. Brazil Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.5.9. Mexico
11.5.9.1. Overview
11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.9.3. Mexico Market Size and Forecast, By Enzyme, 2020 - 2033 (US$ Million)
11.5.9.4. Mexico Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
11.5.9.5. Mexico Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.5.9.6. Mexico Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.5.10. Argentina
11.5.10.1. Overview
11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.10.3. Argentina Market Size and Forecast, By Enzyme, 2020 - 2033 (US$ Million)
11.5.10.4. Argentina Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
11.5.10.5. Argentina Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.5.10.6. Argentina Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.5.11. Colombia
11.5.11.1. Overview
11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.11.3. Colombia Market Size and Forecast, By Enzyme, 2020 - 2033 (US$ Million)
11.5.11.4. Colombia Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
11.5.11.5. Colombia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.5.11.6. Colombia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.5.12. Rest of LATAM
11.5.12.1. Overview
11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.12.3. Rest of LATAM Market Size and Forecast, By Enzyme, 2020 - 2033 (US$ Million)
11.5.12.4. Rest of LATAM Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
11.5.12.5. Rest of LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.5.12.6. Rest of LATAM Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.6. Middle East and Africa (MEA)
11.6.1. Overview
11.6.2. In-vitro Diagnostics Enzymes Key Manufacturers in Middle East and Africa
11.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.6.4. MEA Market Size and Forecast, By Enzyme, 2020 - 2033 (US$ Million)
11.6.5. MEA Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
11.6.6. MEA Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6.7. MEA Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.6.8. Saudi Arabia
11.6.8.1. Overview
11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.8.3. Saudi Arabia Market Size and Forecast, By Enzyme, 2020 - 2033 (US$ Million)
11.6.8.4. Saudi Arabia Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
11.6.8.5. Saudi Arabia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6.8.6. Saudi Arabia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.6.9. United Arab Emirates
11.6.9.1. Overview
11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.9.3. United Arab Emirates Market Size and Forecast, By Enzyme, 2020 - 2033 (US$ Million)
11.6.9.4. United Arab Emirates Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
11.6.9.5. United Arab Emirates Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6.9.6. United Arab Emirates Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.6.10. Israel
11.6.10.1. Overview
11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.10.3. Israel Market Size and Forecast, By Enzyme, 2020 - 2033 (US$ Million)
11.6.10.4. Israel Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
11.6.10.5. Israel Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6.10.6. Israel Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.6.11. Turkey
11.6.11.1. Overview
11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.11.3. Turkey Market Size and Forecast, By Enzyme, 2020 - 2033 (US$ Million)
11.6.11.4. Turkey Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
11.6.11.5. Turkey Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6.11.6. Turkey Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.6.12. Algeria
11.6.12.1. Overview
11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.12.3. Algeria Market Size and Forecast, By Enzyme, 2020 - 2033 (US$ Million)
11.6.12.4. Algeria Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
11.6.12.5. Algeria Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6.12.6. Algeria Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.6.13. Egypt
11.6.13.1. Overview
11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.13.3. Egypt Market Size and Forecast, By Enzyme, 2020 - 2033 (US$ Million)
11.6.13.4. Egypt Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
11.6.13.5. Egypt Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6.13.6. Egypt Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.6.14. Iran
11.6.14.1. Overview
11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.14.3. Iran Market Size and Forecast, By Enzyme, 2020 - 2033 (US$ Million)
11.6.14.4. Iran Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
11.6.14.5. Iran Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6.14.6. Iran Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.6.15. Qatar
11.6.15.1. Overview
11.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.15.3. Qatar Market Size and Forecast, By Enzyme, 2020 - 2033 (US$ Million)
11.6.15.4. Qatar Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
11.6.15.5. Qatar Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6.15.6. Qatar Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.6.16. Rest of MEA
11.6.16.1. Overview
11.6.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.16.3. Rest of MEA Market Size and Forecast, By Enzyme, 2020 - 2033 (US$ Million)
11.6.16.4. Rest of MEA Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
11.6.16.5. Rest of MEA Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6.16.6. Rest of MEA Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
12. Key Vendor Analysis- In-vitro Diagnostics Enzymes Industry
12.1. Competitive Benchmarking
12.1.1. Competitive Dashboard
12.1.2. Competitive Positioning
12.2. Company Profiles
12.2.1. Merck KGaA
12.2.2. Codexis Inc.
12.2.3. F. Hoffmann-La Roche Ltd.
12.2.4. Amano Enzyme Inc.
12.2.5. Advanced Enzymes Technologies Ltd.
12.2.6. Biocatalysts Ltd.
12.2.7. Amicogen Inc.
12.2.8. Dyadic International Inc.
12.2.9. BBI Solutions
12.2.10. Affymetrix (Thermo Fisher Scientific)
12.2.11. American Laboratories Inc.
12.2.12. Others
13. 360 Degree AnalystView
14. Appendix
14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL IN-VITRO DIAGNOSTICS ENZYMES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Merck KGaA
- Codexis Inc.
- F. Hoffmann-La Roche Ltd.
- Amano Enzyme Inc.
- Advanced Enzymes Technologies Ltd.
- Biocatalysts Ltd.
- Amicogen Inc.
- Dyadic International Inc.
- BBI Solutions
- Affymetrix (Thermo Fisher Scientific)
- American Laboratories Inc.
- Others
GLOBAL IN-VITRO DIAGNOSTICS ENZYMES MARKET, BY ENZYME- MARKET ANALYSIS, 2020 - 2033
- Proteases
- Polymerase & Transcriptase
- Ribonuclease
- Others
GLOBAL IN-VITRO DIAGNOSTICS ENZYMES MARKET, BY DISEASE- MARKET ANALYSIS, 2020 - 2033
- Diabetes
- Oncology
- Cardiology
- Infectious disease
- HIV
- Hepatitis
- COVID-19 testing
- Others
- Nephrology
- Autoimmune diseases
- Others
GLOBAL IN-VITRO DIAGNOSTICS ENZYMES MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2020 - 2033
- Clinical Chemistry
- Molecular Diagnostics
- NGS Assays
- PCR Assays
- Others
- Histology Assays
- Others
GLOBAL IN-VITRO DIAGNOSTICS ENZYMES MARKET, BY END USE- MARKET ANALYSIS, 2020 - 2033
- Contract Research Organizations (CROs)
- Academic Labs
- Hospital & Diagnostic Labs
- Pharma & Biotech
- Others
GLOBAL IN-VITRO DIAGNOSTICS ENZYMES MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
